Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.
Source: [ScienceDaily](https://www.sciencedaily.com/releases/2026/07/260724061439.htm)